BLACKROCK HEALTH SCIENCES TRUST |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.06 USD | +0.05% |
|
+0.67% | -3.46% |
| Sales 2022 | 7.73M 617M | Sales 2023 | 8.19M 654M | Capitalization | 508M 40.6B |
|---|---|---|---|---|---|
| Net income 2022 | -26M -2.08B | Net income 2023 | 20M 1.6B | EV / Sales 2022 | 70.9 x |
| Net Debt 2022 | 676K 53.96M | Net Debt 2023 | 60.15K 4.8M | EV / Sales 2023 | 62.1 x |
| P/E ratio 2022 |
-22.8
x | P/E ratio 2023 |
28.2
x | Employees | - |
| Yield 2022 |
5.87% | Yield 2023 |
6.32% | Free-Float | 100% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | +0.05% | ||
| 1 week | +0.67% | ||
| Current month | -5.74% | ||
| 1 month | -5.74% | ||
| 3 months | -4.66% | ||
| 6 months | +9.94% | ||
| Current year | -3.46% |
1 week
38.89
39.49
1 month
38.4341.55
Current year
38.4342.86
1 year
35.5343.19
3 years
35.5349.98
5 years
27.0050.94
10 years
27.0050.94
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 60 | 31/12/10 | |
Trent Walker
DFI | Director of Finance/CFO | 50 | 31/12/20 |
Charles Park
CMP | Compliance Officer | 57 | 31/12/13 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Frank Fabozzi
BRD | Director/Board Member | 76 | 31/12/06 |
W. Kester
BRD | Director/Board Member | 73 | 31/12/06 |
| Chief Executive Officer | 60 | 31/12/10 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 39.06 | +0.05% | 24,850 |
| 25/04/24 | 39.04 | -0.66% | 23,185 |
| 24/04/24 | 39.3 | +0.03% | 22,447 |
| 23/04/24 | 39.29 | +0.72% | 13,845 |
| 22/04/24 | 39.01 | +0.54% | 28,699 |
Delayed Quote Nyse, April 26, 2024 at 09:10 pm
More quotes
BlackRock Health Sciences Trust (the Trust) is a closed-end management investment company. The Trust investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, approximately 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry. The Trust is focused on achieving its goal primarily by investing in a portfolio of equity securities and also by employing a strategy of writing (selling) call and put options. The Trust invests in a portfolio of sectors, which include biotechnology, health care equipment and supplies, life sciences tools and services, and pharmaceuticals. BlackRock Advisors, LLC acts as the manager of the Trust.
Sector
Closed End Funds
| 1st Jan change | Capi. | |
|---|---|---|
| -3.46% | 491M | |
| +3.74% | 12.61B | |
| +5.50% | 9.01B | |
| -3.20% | 5.41B | |
| +2.44% | 5.25B | |
| +5.63% | 5.19B | |
| +14.36% | 4.48B | |
| +16.67% | 4.44B | |
| +1.53% | 4B | |
| +1.56% | 3.75B |
- Stock Market
- Equities
- BME Stock
